{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:42:27Z","timestamp":1790012547519,"version":"4.0.1"},"reference-count":52,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver"],"published-print":{"date-parts":[[2001,12]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold><jats:italic>Aims\/Background:<\/jats:italic>The aim of this review was to determine the benefits and adverse effects of propylthiouracil for patients with alcoholic liver disease.<jats:italic>Methods<\/jats:italic>: Systematic Cochrane Review of randomised clinical trials. The Cochrane Hepato\u2010Biliary Controlled Clinical Trials Register, The Cochrane Library, MEDLINE, and full text searches were combined. All analyses were performed according to the intention\u2010to\u2010treat method. Only randomised clinical trials studying patients with alcoholic steatosis, alcoholic fibrosis, alcoholic hepatitis and\/or alcoholic cirrhosis were included. Interventions encompassed propylthiouracil at any dose<jats:italic>versus<\/jats:italic>placebo or no intervention. The trials could be double\u2010blind, single\u2010blind or unblinded.<jats:italic>Results<\/jats:italic>: Six randomised clinical trials randomising 710 patients demonstrated no significant effects of propylthiouracil<jats:italic>versus<\/jats:italic>placebo on mortality (Peto odds ratio (OR) 0.91, 95% confidence interval (CI) 0.59 to 1.40), liver\u2010related mortality (OR 0.78, CI 0.45 to 1.33), complications to the liver disease (OR 1.14, CI 0.58 to 2.24), and liver histology. Propylthiouracil was associated with a nonsignificant trend toward an increased risk of nonserious adverse events (OR 1.49, CI 0.74 to 2.99) and with the rare occurrence of serious adverse events (leukopenia).<jats:italic>Conclusions:<\/jats:italic>This systematic review could not demonstrate any significant effect of propylthiouracil on any clinically important outcomes (mortality, liver\u2010related mortality, liver complications and liver histology) of patients with alcoholic liver disease.<\/jats:p>","DOI":"10.1034\/j.1600-0676.2001.210606.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T10:24:16Z","timestamp":1047464656000},"page":"398-404","source":"Crossref","is-referenced-by-count":35,"title":["Meta\u2010analysis of propylthiouracil for alcoholic liver disease \u2013 a Cochrane Hepato\u2010Biliary Group Review"],"prefix":"10.1111","volume":"21","author":[{"given":"A.","family":"Rambaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1185","volume-title":"Oxford Textbook of Clinical Hepatology","author":"Morgan M Y","year":"1999"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196804182781602"},{"key":"e_1_2_6_4_2","first-page":"2052","article-title":"Liver hypermetabolic state after chronic ethanol consumption: hormonal interrelationships and pathogenic implications","volume":"34","author":"Israel Y","year":"1975","journal-title":"Fed Proc"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1980.tb00022.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198106060-00001"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-4-199408150-00010"},{"key":"e_1_2_6_8_2","first-page":"210","article-title":"Inhibitory effects of antithyroid drugs on oxygen radical formation in human neutrophils","volume":"112","author":"Imamura M","year":"1986","journal-title":"Acta Endocrinol"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840180228"},{"key":"e_1_2_6_10_2","first-page":"1233","article-title":"Effect of antithyroid drugs on hydroxyl radical formation a alpha\u20101\u2010proteinase inhibitor inactivation by neutrophils: therapeutic implications","volume":"285","author":"Ross A D","year":"1998","journal-title":"Pharmacol Exp Ther"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.3.1137"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(87)90211-5"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(88)90004-X"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0016-5085(79)80136-5","article-title":"Effect of short\u2010term therapy with propylthiouracil in patients with alcoholic liver disease","volume":"76","author":"Orrego H","year":"1979","journal-title":"Gastroenterology"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0016-5085(82)80257-6","article-title":"Double\u2010blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis","volume":"82","author":"Hall\u00e9 P","year":"1982","journal-title":"Gastroenterology"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198712033172301"},{"key":"e_1_2_6_17_2","first-page":"221","article-title":"Diagnosis and treatment of alcoholic liver disease in Europe","volume":"6","author":"Gluud C","year":"1993","journal-title":"Gastroenterol Int"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","unstructured":"RambaldiA&GluudA.Propylthiouracil for alcoholic liver disease. Cochrane Library (Protocol for a Cochrane Review). In:the Cochrane Library Issue 4 2000. Oxford:Update Software.","DOI":"10.1002\/14651858.CD002800"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520290060030"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)01085-X"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-11-200112040-00010"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(95)00134-4"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(97)00150-5"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(89)90320-6"},{"key":"e_1_2_6_26_2","first-page":"A339","volume-title":"Propylthiouracil in acute alcoholic hepatitis.","author":"Rodriguez\u2010Rodriguez E","year":"1993"},{"key":"e_1_2_6_27_2","first-page":"194A","article-title":"Treatment of severe alcoholic hepatitis with propylthiouracil (PTU)","volume":"76","author":"Serrano\u2010Cancino H","year":"1981","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_28_2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0016-5085(79)80137-7","article-title":"Thyroid hormones in alcoholic liver disease. Effect of treatment with 6\u2010n\u2010propylthiouracil","volume":"76","author":"Israel Y","year":"1979","journal-title":"Gastroenterology"},{"key":"e_1_2_6_29_2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0016-5085(82)80050-4","article-title":"Propylthiouracil treatment for alcoholic hepatitis: the case of the missing thirty","volume":"83","author":"Orrego H","year":"1982","journal-title":"Gastroenterology"},{"key":"e_1_2_6_30_2","first-page":"82","article-title":"Chronic propylthiouracil treatment increases survival in patients with alcoholic liver disease","volume":"6","author":"Orrego H","year":"1986","journal-title":"Hepatology"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(94)80005-7"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91649-2"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198806023182219"},{"key":"e_1_2_6_34_2","first-page":"A644","article-title":"Short\u2010term therapy with propylthiouracil (PTU) for alcoholic hepatitis (AH). A clinical, biochemical and histological randomized trial about 25 patients","volume":"96","author":"Pierrugues R","year":"1989","journal-title":"Gastoenterology"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80427-7"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80429-1"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1080\/15513819609169310"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005350050167"},{"key":"e_1_2_6_39_2","first-page":"1071","article-title":"Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow\u2010up study","volume":"89","author":"Huang M\u2010J","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1089\/10507250050137815"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.47.467"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(82)90536-6"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840100303"},{"key":"e_1_2_6_44_2","unstructured":"IoannidisJ P A&LauJ.What certainty can there be on how much treatments work? Empirical insight from recursive cumulative meta\u2010analyses. (Abstract). 8th International Cochrane Colloquium. October 2000 21."},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2001.021002129.x"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.1.113"},{"key":"e_1_2_6_47_2","first-page":"564","article-title":"Testosterone and alcoholic cirrhosis. Epidemiologic, pathophysiologic and therapeutic studies in men","volume":"35","author":"Gluud C","year":"1988","journal-title":"Dan Med Bull"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150115"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00139.x"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840140624"},{"key":"e_1_2_6_51_2","first-page":"85","article-title":"Beneficial effects of polyenylphosphatidylcholine (PPC) in alcoholic and non\u2010alcoholic liver injury","volume":"121","author":"Lieber C S","year":"2001","journal-title":"Falk Symposium"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91897-X"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80420-1"}],"container-title":["Liver"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0676.2001.210606.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0676.2001.210606.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0676.2001.210606.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T10:17:50Z","timestamp":1733566670000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0676.2001.210606.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["10.1034\/j.1600-0676.2001.210606.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0676.2001.210606.x","archive":["Portico"],"relation":{},"ISSN":["0106-9543","1600-0676"],"issn-type":[{"value":"0106-9543","type":"print"},{"value":"1600-0676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}